Parkinsonian Disorders

"Parkinsonian Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Descriptor ID	D020734
MeSH Number(s)	C10.228.140.079.862 C10.228.662.600
Concept/Terms	Parkinsonian Disorders Parkinsonian Disorders Parkinsonian Syndrome Parkinsonism Parkinsonian Syndromes Parkinsonian Diseases Autosomal Dominant Parkinsonism Autosomal Dominant Parkinsonism Dominant Parkinsonism, Autosomal Parkinsonism, Autosomal Dominant Autosomal Recessive Juvenile Parkinson Disease Autosomal Recessive Juvenile Parkinson Disease Chromosome 6-Linked Autosomal Recessive Parkinsonism Chromosome 6 Linked Autosomal Recessive Parkinsonism Familial Parkinson Disease, Autosomal Recessive Juvenile Parkinson Disease, Autosomal Recessive Juvenile Parkinsonism, Autosomal Recessive Parkinsonism, Early Onset, with Diurnal Fluctuation Parkinsonism, Juvenile, Autosomal Recessive Parkinson Disease 2, Autosomal Recessive Juvenile Parkinsonism, Early-Onset, With Diurnal Fluctuation Parkinson Disease, Juvenile, Autosomal Recessive Parkinson Disease 2 Parkinson Disease Autosomal Recessive, Early Onset Autosomal Recesssive Juvenile Parkinsonism Parkinson Disease, Familial, Autosomal Recessive Ramsay Hunt Paralysis Syndrome Ramsay Hunt Paralysis Syndrome Familial Juvenile Parkinsonism Familial Juvenile Parkinsonism Juvenile Parkinsonism, Familial Parkinsonism, Familial Juvenile Parkinsonism, Experimental Parkinsonism, Experimental Experimental Parkinsonisms Parkinsonisms, Experimental Parkinson Disease, Experimental Experimental Parkinsonism, MPTP-Induced Experimental Parkinsonism, MPTP Induced Parkinsonism, MPTP-Induced Experimental MPTP-Induced Experimental Parkinsonism MPTP Induced Experimental Parkinsonism Experimental Parkinson Disease Diseases, Experimental Parkinson Experimental Parkinson Diseases Parkinson Diseases, Experimental Experimental Parkinsonism Parkinsonism, Juvenile Parkinsonism, Juvenile Juvenile Parkinsonism Juvenile Parkinsonisms Parkinsonisms, Juvenile Parkinson Disease, Juvenile Juvenile Parkinson Disease Autosomal Dominant Juvenile Parkinson Disease Autosomal Dominant Juvenile Parkinson Disease Juvenile Parkinson Disease, Autosomal Dominant Parkinsonism, Juvenile, Autosomal Dominant Parkinson Disease, Autosomal Dominant. Juvenile Parkinson Disease, Juvenile, Autosomal Dominant Autosomal Dominant Juvenile Parkinsonism Juvenile Parkinsonism, Autosomal Dominant Autosomal Recessive Parkinsonism Autosomal Recessive Parkinsonism Parkinsonism, Autosomal Recessive Recessive Parkinsonism, Autosomal

Below are MeSH descriptors whose meaning is more general than "Parkinsonian Disorders".

Diseases [C]
Nervous System Diseases [C10]
Central Nervous System Diseases [C10.228]
Brain Diseases [C10.228.140]
Basal Ganglia Diseases [C10.228.140.079]
Parkinsonian Disorders [C10.228.140.079.862]
Movement Disorders [C10.228.662]
Parkinsonian Disorders [C10.228.662.600]

Below are MeSH descriptors whose meaning is more specific than "Parkinsonian Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Parkinsonian Disorders" by people in this website by year, and whether "Parkinsonian Disorders" was a major or minor topic of these publications.

Bar chart showing 35 publications over 18 distinct years, with a maximum of 4 publications in 2016 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2002	2	0	2
2004	1	0	1
2005	1	0	1
2007	2	1	3
2008	3	0	3
2009	2	0	2
2010	2	0	2
2012	1	0	1
2014	2	1	3
2015	1	0	1
2016	4	0	4
2018	1	1	2
2019	3	1	4
2021	1	0	1
2022	1	0	1
2024	0	2	2
2025	1	0	1

Below are the most recent publications written about "Parkinsonian Disorders" by people in Profiles.

Firouzan B, Ghasemi R, Tetteh MT, Matson JB, Kashfi K. NOSH-aspirin (NBS-1120) attenuates motor defects and dopaminergic neuron degeneration in a rat model of Parkinson's disease. Eur J Pharmacol. 2025 Sep 05; 1002:177733.

View in: PubMed
Morino H, Kurashige T, Matsuda Y, Ono M, Sahara N, Miyasaka T, Soeda Y, Shimada H, Yamazaki Y, Takahashi T, Izumi Y, Ito H, Maruyama H, Higuchi M, Arihiro K, Suhara T, Takashima A, Kawakami H. Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation. Mov Disord Clin Pract. 2024 Jun; 11(6):720-727.

View in: PubMed
Buchman AS, Yu L, Oveisgharan S, Zammit AR, Wang T, Shulman JM, VanderHorst V, Nag S, Bennett DA. Parkinson's Disease and Other Alzheimer's Disease and Related Dementia Pathologies and the Progression of Parkinsonism in Older Adults. J Alzheimers Dis. 2024; 100(s1):S197-S209.

View in: PubMed
Rodichkin AN, Edler MK, McGlothan JL, Guilarte TR. Pathophysiological studies of aging Slc39a14 knockout mice to assess the progression of manganese-induced dystonia-parkinsonism. Neurotoxicology. 2022 12; 93:92-102.

View in: PubMed
Bailey M, Shulman LM, Ryan D, Ouyang B, Shulman JM, Buchman AS, Bennett DA, Barnes LL, Hall DA. Frequency of Parkinsonism and Parkinson Disease in African Americans in the Chicago Community. J Gerontol A Biol Sci Med Sci. 2021 06 14; 76(7):1340-1345.

View in: PubMed
Do J, McKinney C, Sharma P, Sidransky E. Glucocerebrosidase and its relevance to Parkinson disease. Mol Neurodegener. 2019 08 29; 14(1):36.

View in: PubMed
Ryan E, Seehra G, Sharma P, Sidransky E. GBA1-associated parkinsonism: new insights and therapeutic opportunities. Curr Opin Neurol. 2019 08; 32(4):589-596.

View in: PubMed
von Coelln R, Dawe RJ, Leurgans SE, Curran TA, Truty T, Yu L, Barnes LL, Shulman JM, Shulman LM, Bennett DA, Hausdorff JM, Buchman AS. Quantitative mobility metrics from a wearable sensor predict incident parkinsonism in older adults. Parkinsonism Relat Disord. 2019 08; 65:190-196.

View in: PubMed
Sampath C, Kalpana R, Ansah T, Charlton C, Hale A, Channon KM, Srinivasan S, Gangula PR. Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease. Dig Dis Sci. 2019 12; 64(12):3502-3517.

View in: PubMed
Buchman AS, Yu L, Wilson RS, Leurgans SE, Nag S, Shulman JM, Barnes LL, Schneider JA, Bennett DA. Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies. Neurology. 2019 04 16; 92(16):e1821-e1830.

View in: PubMed

People

Explore

Similar Concepts

Top Journals